U
XBI icon

UBS’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

UBS’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$75.7M Buy
1,455,717
+90,201
+7% +$4.6M 0.06% 342
2014
Q2 		$70.1M Buy
1,365,516
+847,158
+163% +$38.2M 0.05% 339
2014
Q1 		$24.6M Buy
518,358
+66,258
+15% +$3.39M 0.02% 690
2013
Q4 		$19.6M Sell
452,100
-50,796
-10% -$2.1M 0.02% 820
2013
Q3 		$21.7M Buy
502,896
+44,904
+10% +$1.82M 0.02% 674
2013
Q2 		$15.9M Buy
+457,992
New +$16.1M 0.02% 768

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

UBS's XBI Position: Q3 2014 in Review

UBS increased its State Street SPDR S&P Biotech ETF (XBI) stake by 6.6% in Q3 2014, buying an estimated $4.6M and bringing the position to 1,455,717 shares worth $75.7M. The position accounts for 0.06% of the portfolio, ranked #342.

UBS first reported a position in XBI in Q2 2013 and has held it in 6 quarters since. 129 funds tracked by Wall St. Rank hold XBI as of Q3 2014.

  • UBS held 1,455,717 shares of State Street SPDR S&P Biotech ETF worth $75.7M as of Q3 2014.
  • UBS bought 90,201 State Street SPDR S&P Biotech ETF shares in Q3 2014, an estimated $4.6M.
  • State Street SPDR S&P Biotech ETF made up 0.06% of UBS's portfolio in Q3 2014, its #342 holding.
  • UBS first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 6 quarters since.
  • 129 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.